A practical guide to navigating EU IVDR requirements when building or procuring software for in-vitro diagnostic laboratories.
The EU In Vitro Diagnostic Regulation (IVDR 2017/746) replaced the former IVD Directive in May 2022, fundamentally changing how diagnostic laboratories and their software suppliers approach compliance. If your lab relies on custom or commercial software for test management, result interpretation, or quality control, IVDR almost certainly affects you.
This article walks through the key milestones and practical steps every lab should consider.
IVDR introduces a risk-based classification system (Classes A through D) that applies not only to physical devices but also to standalone software used in diagnostics. Software that interprets patient data or drives clinical decisions may be classified as a Class C or even Class D device, triggering stringent conformity assessment requirements.
Key question: Does your software provide information used to make decisions about individual patients? If yes, it is likely an IVD medical device under IVDR.
The European Commission has extended transition periods through 2028 for certain device classes. However, waiting until the deadline is risky. Notified Body capacity is limited, and conformity assessments can take 12–18 months.
Labs modernizing their infrastructure should treat IVDR compliance as a design constraint, not an afterthought. Choosing software vendors who understand the regulatory landscape - and who build with compliance in mind - saves significant rework down the line.
Bottom line: Start your IVDR gap analysis now, prioritize high-risk software, and build compliance into your digital transformation roadmap.
Whether you're modernizing your infrastructure, navigating compliance, or building new software — we can help.
Book a 30-min Call